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Mammalian RNA polymerase II (Pol II) transcription
termination is an essential step in protein-coding
gene expression that is mediated by pre-mRNA pro-
cessing activities and DNA-encoded terminator ele-
ments. Although much is known about the role of
pre-mRNA processing in termination, our under-
standing of the characteristics and generality of
terminator elements is limited. Whereas promoter
databases list up to 40,000 known and potential Pol
II promoter sequences, fewer than ten Pol II termi-
nator sequences have been described. Using our
knowledge of the human b-globin terminator mecha-
nism, we have developed a selection strategy for
mapping mammalian Pol II terminator elements. We
report the identification of 78 cotranscriptional cleav-
age (CoTC)-type terminator elements at endogenous
gene loci. The results of this analysis pave theway for
the full understanding of Pol II termination pathways
and their roles in gene expression.INTRODUCTION
The transcription cycle consists of three stages. Initiation, where
RNA polymerase engages with the DNA template, followed by
elongation where it translocates along the DNA template synthe-
sizing the RNA copy of the gene and finally termination, where
polymerase disengages from the DNA template. In mammals,
promoter and terminator DNA sequences are well described
for genes transcribed by RNA polymerases I and III (Richard
and Manley, 2009). For genes transcribed by RNA polymerase
II (Pol II), including all protein coding genes, there is an extensive
literature describing promoter sequences. The Mammalian Pro-
moter Database lists 24,967 known and an additional 17,926
potential human Pol II promoters (Gupta et al., 2011); however,
fewer than ten verified mammalian Pol II terminator sequences
have been described (Proudfoot, 1989; Richard and Manley,
2009).
The major reason for this discrepancy is that Pol II termination
is coupled to the complex steps involved in pre-mRNA process-1080 Cell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authorsing and is entirely dependent upon the presence of a functional
poly(A) signal (Whitelaw and Proudfoot, 1986; Connelly and
Manley, 1988). Pre-mRNA cleavage at the poly(A) site, mediated
by the 30 end processing complex (Shi et al., 2009), generates
two RNA products; a 50 cleavage product that is stabilized by
polyadenylation as it is processed into mRNA and a 30 cleavage
product that is subject to rapid degradation by the 50-30 exonu-
clease Xrn2. Such Xrn2-mediated transcript degradation has
been shown to have a role in Pol II termination (West et al.,
2004). The above could lead one to conclude that the poly(A)
site sequence, typically characterized by the hexanucleotide
sequence AATAAA followed by a GU/U rich region (Proudfoot,
2011), is the sole Pol II terminator signal. That this is indeed the
case, in lower eukaryotes, is supported by a number of studies,
mainly in yeast, which provide a detailed understanding of the
roles of a host of RNA processing factors in the Pol II termination
process (Richard and Manley, 2009; Kuehner et al., 2011). For
mammalian genes, however, the poly(A) signal is not the only
sequence that is required for Pol II termination. Studies in our
laboratory and others have shown the existence of dedicated
DNA-encoded Pol II terminator elements located downstream
of poly(A) signals (Proudfoot, 1989; Tantravahi et al., 1993; Dye
and Proudfoot, 2001; Plant et al., 2005; Gromak et al., 2006;
West et al., 2006). From these studies, it appears that there are
two broad categories of terminator sequence; G-rich sequences
that enhance poly(A) site cleavage and subsequent Pol II termi-
nation by pausing Pol II near to the poly(A) signal (Proudfoot
et al., 2002; Gromak et al., 2006) and AT-rich terminator se-
quences, located 1–2 kb downstream of the poly(A) site, which
mediate rapid cotranscriptional cleavage of nascent transcripts,
prior to poly(A) site cleavage (Dye and Proudfoot, 2001; Plant
et al., 2005; West et al., 2006). RNA degradation initiating at
cotranscriptional cleavage (CoTC) sites leads to release of Pol
II and associated unprocessed pre-mRNA, from the DNA
template (West et al., 2008). This distinguishing feature of
CoTC-mediated termination is supported by electron micro-
scopic studies in Drosophila that show that release of pre-
mRNA from transcription sites prior to 30 end processing is a
common occurrence (Osheim et al., 2002).
One of the major reasons for the paucity of mammalian Pol II
terminator sequences in the literature is that examination of
termination mechanisms is hindered by the technical difficulty
of mapping nascent transcripts in nuclear run on experiments
(Proudfoot, 1989). Here we have used a CLIP-seq strategy (Lica-
talosi et al., 2008) to distinguish pre-mRNAs that are released
from the DNA template before cleavage at the poly(A) site, in
order to identify genes that utilize the CoTC termination
pathway. Thorough testing of potential terminator sequences
from a number of candidate gene loci shows that we have
isolated authentic Pol II terminators and indicates that CoTC-
mediated termination is a feature of a significant proportion of
mammalian genes.
RESULTS
CLIP-seq-Based CoTC Terminator Mapping Strategy
Detailed transcriptional analysis of the human b-globin gene has
shown that CoTC of b-globin 30 flanking region transcripts leads
to release of Pol II and associated pre-mRNA, from the chro-
matin template prior to cleavage/polyadenylation at the poly(A)
site. Interestingly, 30 end processing of these released pre-
mRNAs (referred to herein as unprocessed pre-mRNAs) occurs
posttranscriptionally, in the nucleoplasm (Figure 1A) (West
et al., 2008). Following on from these observations, we have
developed a strategy, using in vivo UV crosslinking immunopre-
cipitation (IP) with antibody to the CstF-64 pre-mRNA process-
ing factor (MacDonald et al., 1994), to select such unprocessed
nucleoplasmic pre-mRNAs in order to identify genes that use the
CoTC termination pathway.
In an initial pilot experiment, HeLa cells transiently transfected
with a b-globin minigene construct bTERM (that has an HIV-LTR
promoter) and a plasmid encoding the viral transactivator Tat
(pTat), were subjected to UV crosslinking followed by nuclear
fractionation into chromatin (Ch) and nucleoplasm (N) fractions,
as described previously (West et al., 2008). IP was then con-
ducted on the nucleoplasm fraction using CstF-64 antibody
to precipitate unprocessed b-globin pre-mRNA, which was
detected by RT-PCR using b-globin and control 7SK snRNA
primers (Figure 1B). In lane 1, the detection of PCR products rep-
resenting unprocessed b-globin pre-mRNA and mature 7SK
transcripts, confirms the presence of both RNA species in the
input nucleoplasm fraction. In control lane 2, no PCR products
are detected confirming that 7SK and b-globin pre-mRNA do
not interact with IgG. In lane 3, RT-PCR of nucleoplasmic RNA
precipitated with the CstF-64 antibody shows the presence of
a PCR product for b-globin but not 7SK, confirming a specific
interaction of CstF-64 with nucleoplasmic b-globin pre-mRNA.
We next performed CstF-64 IP, combined with high through-
put sequencing (CLIP-seq) (Licatalosi et al., 2008), to identify
endogenous CstF-64 interacting nucleoplasmic pre-mRNAs.
HeLa cells transiently transfected with bTERM and pTat were
UV crosslinked prior to nuclear fractionation. The nucleoplasm
fraction was then treated with high (40 U/ml; lanes 1–4) or low
(4 U/ml; lanes 5–8) RNaseI before IP with CstF-64 and IgG
antibodies. Immunoprecipitated RNA was 50 end-labeled with
[g-32P] ATP and protein RNA complexes were separated by
PAGE and transferred to a nitrocellulose membrane (Figure 1C).
IP of UV-treated cells with CstF-64 antibody (lanes 4 and 8)
results in two prominent radiolabeled bands. (The absence of
bands in control lanes 1–3 and 5–7, confirms the specificity of
the CstF-64 IP experiment; see legend for full details). The lowerC70 kDa band is the expected size for CstF-64 and the upper
200 kDa band is possibly a CstF-64 dimer. The bands detected
in lane 8 (4 U/ml) are relatively weaker than those detected in lane
4 (40 U/ml) and appear within a radioactive smear extending
from 40–300 kDa, which reflects partial RNA digestion due to
limiting RNaseI. RNA was eluted from the membrane at a
position 20–30 kDa above the 70 kDa CstF-64 band to
obtain CstF-64/RNA complexes containing 50–80 nucleotide
(nt) RNAs. Eluted RNAs were ligated to adaptors for reverse tran-
scription and PCR amplification. This experiment was repeated
twice more on untransfected cells. PCR products from each
experiment were analyzed by high throughput sequencing
(HITS). A total of 1,285 CLIP regions were identified, from the
three repeats, which were supported by at least two indepen-
dent read alignments in the pooled samples. These CLIP regions
were significantly enriched in genic (RefSeq+RNA genes) but not
intergenic regions and within genes, they showed significant
enrichment in extended 30 UTR regions, but not in exons or
introns (graphs, Figure 1D). Seventy-eight genes (Table 1) con-
taining CstF-64 CLIP regions within 30 UTRs (i.e., in proximity
to putative poly(A) sites) were selected as CoTC candidates
(see Experimental Procedures for details). Importantly, this list
contains the b-globin gene, as three unique CLIP reads were
mapped in the proximity of its annotated poly(A) site, in the trans-
fected sample (Figure 1E).
CLIP-seq Positive Candidate Pre-mRNAs Are Released
from the DNA Template
According to our hypothesis, the detection of a particular unpro-
cessed pre-mRNA in the nucleoplasm is a marker of CoTC-type
termination occurring at the corresponding gene locus. There-
fore, to further test the CLIP-seq data, we analyzed the nuclear
distribution of unprocessed pre-mRNA, from a subset of
CLIP-seq positive genes, by quantitative radioactive RT-PCR
(qRT-PCR) of chromatin and nucleoplasm fractions (Figure 2A).
Analysis of pre-mRNA in the chromatin (Ch) fraction (lane 1)
shows that unprocessed, presumably nascent, pre-mRNAs are
detected at each of the candidate gene loci. Likewise, for the
nucleoplasm (N) fraction (lane 2), unprocessed pre-mRNA from
each of the candidate gene loci is detected. Quantitative analysis
of the PCR products, in lanes 1 and 2, confirms that significant
amounts of unprocessed pre-mRNA (19%–55%) are released
to the nucleoplasm fraction from the corresponding gene loci
(Figure 2A, graph). Variation in the amount of nucleoplasmic
pre-mRNA, from different genes, may indicate variation in the
efficiency of pre-mRNA release, gene-specific rates of 30 end
processing or differential RNA stability. Importantly, these data
confirm our detection of unprocessed nucleoplasmic pre-
mRNAs in our CLIP-seq analysis and support the hypothesis
that a CoTC-type termination mechanism operates at these
gene loci.
To control for the possibility that the presence of unprocessed
nucleoplasmic pre-mRNA is a general feature of Pol II tran-
scribed genes, we employed the same qRT-PCR strategy to
examine the nuclear distribution of GAPDH, PKM2, and ENO1
pre-mRNAs, as these highly expressed transcripts (Kapranov
et al., 2007) were not detected in our CLIP-seq analysis. As
shown in Figure 2B, analysis of pre-mRNAs in the chromatinell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authors 1081
Figure 1. Isolation of Nucleoplasmic CstF-64-Associated Pre-mRNA
(A) Diagram of the CoTC termination mechanism. The CoTC terminator (red bar) is located downstream of the poly(A) site (pA, green arrowhead) of the human
b-globin gene. b-globin pre-mRNA (curved black line with blue cap) is generated by Pol II (gray icons). 30 flanking region transcripts (red dashed line) are cleaved
by CoTC activity (scissors). Xrn2 (blue icon) degrades the 30 transcript (black dashed line) leading to Pol II and pre-mRNA release from the DNA template. Pre-
mRNA is processed by poly(A) factors including CstF-64 (gray sphere) in the nucleoplasm to mRNA (line with AAAA indicating poly(A) tail).
(B) RT-PCR analysis of immunoprecipitated nucleoplasmic RNA. RNA in control input (lanes 1 and 4) and immunoprecipitated with rabbit IgG (lanes 2 and 5) or
CstF-64 antibody (lanes 3 and 6) was subjected to RT-PCRanalysis using b-globin-specific primers (blue arrows in diagram beside the data panel) and primers for
7SK snRNA. The lack of bands in lanes 4–6 (RTase) confirms the absence of contaminating DNA in all samples.
(C) Purification of CstF-64-RNA covalent complexes by SDS-PAGE following treatment with high (40 U/ml, lanes 1–4) or low (4 U/ml, lanes 5–8) RNaseI. No
protein-RNA complexes were detected in the absence of UV irradiation (lanes 1, 2, 5, and 6) or following control immunoprecipitation with rabbit IgG (lanes 3
and 7), demonstrating the specificity of the CstF-64 antibody/CstF-64-RNA complex interaction. The red dashed box, in lane 8, indicates the area of the gel from
which CstF-64-RNA complexes were eluted for subsequent HITS analysis.
(D) Bar graphs showing the distribution of CLIP reads in annotated genic and intergenic regions (left panel) and in intron, exon, and 30 UTRs of annotated genes
(right panel). P values (brackets) for the significance of relative enrichment, with respect to what would be expected by chance, in the case of a random dis-
tribution, were calculated using a one-sided binomial test. *Indicates significant enrichment (p value < 0.001).
(E) Diagram of the human b-globin gene with CLIP tags (dark blue squares) mapped to the sequence shown below the diagram. The annotated poly(A) site is
indicated in green. Red letters highlight G/U stretches representing potential CstF-64 binding sites.
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(Ch) fraction (lane 1) detected unprocessed, presumably
nascent, pre-mRNAs at each of the candidate gene loci. In lane
2, analysis of the nucleoplasm fraction detected only faint PCR
products representing unprocessed nucleoplasmic pre-mRNAs
from these gene loci. Quantitative analysis of the radiolabeled
RT-PCRproducts derived fromchromatin and nucleoplasm frac-
tions (graph, Figure 2B) shows that unprocessed nucleoplasmic
pre-mRNAs represent merely 4%–7% of total pre-mRNA from
these gene loci. These data provide further validation of the
CLIP-seq experiment and indicate that, on the basis of our selec-
tion criteria (detection of unprocessed nucleoplasmic pre-
mRNA), it is likely that the GAPDH, PKM2, and ENO1 genes do
not employ a CoTC termination mechanism. We predict that
the terminationmechanismemployed at these gene loci is similar
to the previously described pause-type, where poly(A) site cleav-
age precedes Pol II release from the DNA template (Gromak
et al., 2006; West et al., 2008) (diagram, Figure 2B).
Mapping of Terminator Elements at CLIP-seq Positive
Gene Loci
We next developed a strategy to map terminator elements at the
CLIP-seq positive gene loci. Transcript cleavage occurring
downstream of and prior to cleavage at the poly(A) site is an
intrinsic part of the CoTC terminatormechanism (Dye and Proud-
foot, 2001; West et al., 2008) (Figure 1A). Therefore we reasoned
that it would be possible to infer the location of potential CoTC
terminator sequences, in the 30 flanking regions of CLIP-seq pos-
itive genes, by mapping sites of transcript cleavage using an RT-
PCR approach. Total nuclear RNAwas reverse transcribed using
random primers and the resulting cDNA was PCR amplified
using gene-specific primers complementary to 30 flanking region
transcripts. ForCCNB1, PCR amplification was carried out using
a single forward primer (F), located upstream of the CCNB1
poly(A) site, in combination with reverse primers (R1–R5) located
at increasing distance downstream of the poly(A) site in the
CCNB1 30 flanking region (Figure 3A, diagram). PCR amplifica-
tion using the F/R1-R3 primer pairs resulted in the detection of
180 bp, 580 bp, and 1.1 kb bands (lanes 6–8), which correspond
precisely to bands derived from control amplification of genomic
DNA using the same primer pairs (lanes 1–3). PCR amplification
using F/R4 and F/R5 primer pairs does not result in detectable
levels of product (lanes 9 and 10), even though corresponding
PCR products are derived from control amplification of genomic
DNA (lanes 4 and 5). Thus RT-PCR analysis shows that contin-
uous CCNB1 pre-mRNA is detected up to 1.1 kb downstream
of the poly(A) site (lane 8, F/R3 primer pair), with no continuous
RNA detected beyond this point (lanes 9 and 10). From these
data, we estimated that a potential CoTC terminator element
(PCTE) was located between 470–1,780 bp downstream of the
CCNB1 poly(A) site (the region bordered by primers R2 and
R4). This observation is similar to that reported for the b-globin
gene, where significant CoTC activity occurs at a position
1.0 kb downstream of the b-globin poly(A) site (Dye and Proud-
foot, 2001). We next adopted the same terminator mapping
strategy for four other CLIP-seq positive genes (AKIRIN1,
PTCH2, THOC2, and WDR13). Transcript cleavage (30 flanking
region) was mapped to positions 0.8–1.2 kb downstream of
the respective poly(A) sites and was used to estimate the loca-Ction of PCTEs (Figure 3B). Confirmation of these results comes
from control experiments, measuring RT-PCR efficiency on
full-length in vitro transcribed CCNB1, PTCH2, and WDR13 30
flanking region transcripts (Figure S1).
Testing Candidate Terminator Elements
The five newly identified PCTEs were placed in the termination
reporter plasmid (bDTERM) and tested for terminator activity
by RNase protection assay (RPA) (Plant et al., 2005). Nuclear
RNA isolated from HeLa cells transiently transfected with each
of the candidate reporter constructs, positive (bTERM), or nega-
tive (bDTERM) terminator control constructs and pTat, was
hybridized to an antisense radiolabeled riboprobe spanning the
reporter gene HIV-LTR (Figure 4A). Following RNase digestion,
protected products were analyzed by PAGE (Figure 4B). In
lane 1, no protection products were detected, confirming the
absence of b-globin mRNA in untransfected HeLa cells. In lane
2 (bTERM), the prominent 85 nt band, (labeled mRNA) at the
base of the gel, results from hybridization of the riboprobe to
the 50 end of the b-globin mRNA. The weaker 242 nt band
(labeled RT) results from hybridization of the riboprobe to read-
through transcripts derived from Pol II transcription proceeding
around the plasmid into the HIV-LTR. In lane 3 (bDTERM), a
weaker mRNA band was detected together with a prominent
read-through band that reflects increased Pol II read-through
transcription in the absence of the b-globin terminator element.
In lane 4 (bCCNB1), the reduced intensity of the read-through
band shows that the CCNB1 PCTE effectively blocks Pol II
read-through transcription. Furthermore, the corresponding in-
crease in the mRNA band shows that b-globin mRNA recovers
to wild-type level in the presence of the CCNB1 PCTE. The low
level of the read-through band in all candidate PCTE samples
(lanes 5–8 and graph below the data panel) indicates that each
PCTE has terminator activity.
Although RPA is useful for screening terminator activity, it is
an indirect method and read-through transcript levels could
be affected by differential RNA stability. Therefore, we next
employed nuclear run on (NRO) analysis to measure termination
by the CCNB1 and PTCH2 PCTEs. NRO analysis was con-
ducted on nuclei isolated from HeLa cells transfected with
bCCNB1, bPTCH2, and three control constructs (bTERM,
bDTERM, and b4-7) along with pTat. Resulting radiolabeled
nascent transcripts were hybridized to the nylon filter shown
in Figure 4C. For the positive control construct (bTERM) prom-
inent hybridization signals are detected in the gene body and
post poly(A) site region (probes P, B3, and B4, respectively)
and background level signals are detected over probes A and
U3, which are located downstream of the terminator, showing
that efficient termination occurs before Pol II reaches region A
of the plasmid template (Dye and Proudfoot, 2001). For the
termination negative control (bDTERM), in the absence of the
terminator sequence, hybridization signals are detected over
all probes P-U3. The presence of prominent signals over
probes A and U3 shows that in the absence of the terminator
Pol II transcribes the entire plasmid. The transcription profiles
resulting from NRO analysis of bCCNB1 and bPTCH2 are
essentially identical to bTERM, with prominent radioactive sig-
nals detected over probes P, B3 and B4 and only backgroundell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authors 1083
Table 1. List of CLIP-Seq-Positive CoTC Candidate Genes
Gene Symbol Transcript_ID Gene Name
AGFG1 NM_004504 ArfGAP with FG repeats 1
AKIRIN1 NM_001136275 akirin 1
BCAP29 NM_001008405 B cell receptor-associated protein 29
BLCAP NM_006698 bladder cancer-associated protein
BRD9 NM_001009877 bromodomain containing 9
C5orf28 NM_022483 chromosome 5 open reading frame 28
C5orf35 NM_153706 chromosome 5 open reading frame 35
CANX NM_001746 Calnexin
CCDC72 NM_015933 coiled-coil domain containing 72
CCNB1 NM_031966 cyclin B1
CD55 NM_001114752 CD55 molecule, decay accelerating factor for complement (Cromer blood group)
CELF1 NM_001172640 CUGBP Elav-like family member 1
CHST15 NM_015892 carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15
CYBRD1 NM_024843 cytochrome b reductase 1
CYFIP1 NM_014608 cytoplasmic FMR1 interacting protein 1
DDX3X NM_001356 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked
DDX58 NM_014314 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
DMD NM_004019 Dystrophin
DNAJC6 NM_014787 DnaJ (Hsp40) homolog, subfamily C, member 6
FAM200B NM_001145191 family with sequence similarity 200, member B
FAR1 NM_032228 fatty acyl CoA reductase 1
GNAI3 NM_006496 guanine nucleotide binding protein (G protein), a inhibiting activity polypeptide 3
GNB2L1 NM_006098 guanine nucleotide binding protein (G protein), b polypeptide 2-like 1
HADHA NM_000182 hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), a subunit
HBB NM_000518 hemoglobin, b
HES7 NM_001165967 hairy and enhancer of split 7 (Drosophila)
HN1L NM_144570 hematological and neurological expressed 1-like
HNRNPD NM_031369 heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37 kDa)
HNRNPM NM_031203 heterogeneous nuclear ribonucleoprotein M
IRX3 NM_024336 iroquois homeobox 3
KCMF1 NM_020122 potassium channel modulatory factor 1
KLF6 NM_001160125 Kruppel-like factor 6
MAFK NM_002360 v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)
MARK3 NM_001128920 MAP/microtubule affinity-regulating kinase 3
MIB1 NM_020774 mindbomb homolog 1 (Drosophila)
MRPL30 NM_145212 mitochondrial ribosomal protein L30
MRPS14 NM_022100 mitochondrial ribosomal protein S14
MYC NM_002467 v-myc myelocytomatosis viral oncogene homolog (avian)
NCS1 NM_001128826 frequenin homolog (Drosophila)
NQO2 NM_000904 NAD(P)H dehydrogenase, quinone 2
NUCKS1 NM_022731 nuclear casein kinase and cyclin-dependent kinase substrate 1
NUFIP2 NM_020772 nuclear fragile X mental retardation protein interacting protein 2
OMA1 NM_145243 OMA1 homolog, zinc metallopeptidase (Saccharomyces cerevisiae)
PRPF4B NM_003913 similar to hCG1820375; PRP4 pre-mRNA processing factor 4 homolog B (yeast)
PSIP1 NM_021144 PC4 and SFRS1 interacting protein 1
PTCH2 NM_001166292 patched homolog 2 (Drosophila)
RAB13 NM_002870 RAB13, member RAS oncogene family; similar to hCG24991
(Continued on next page)
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Table 1. Continued
Gene Symbol Transcript_ID Gene Name
RAPH1 NM_213589 Ras association (RalGDS/AF-6) and Pleckstrin homology domains 1
RBM27 NM_018989 RNA binding motif protein 27
RNASEH1 NM_002936 ribonuclease H1
RNF166 NM_178841 ring finger protein 166
RPL13A NM_012423 ribosomal protein L13a pseudogene
RPL37A NM_000998 ribosomal protein L37a
RRP15 NM_016052 ribosomal RNA processing 15 homolog (S. cerevisiae)
SAC3D1 NM_013299 SAC3 domain containing 1
SAP18 NM_005870 Sin3A-associated protein, 18 kDa
SCAF8 NM_014892 RNA binding motif protein 16
SCLT1 NM_144643 sodium channel and clathrin linker 1
SIK1 NM_173354 salt-inducible kinase 1
TEAD1 NM_021961 TEA domain family member 1 (SV40 transcriptional enhancer factor)
TFAP2A NM_001042425 transcription factor AP-2 a (activating enhancer binding protein 2 a)
THOC2 NM_001081550 THO complex 2
TNRC6A NM_014494 trinucleotide repeat containing 6A
TROAP NM_001100620 trophinin-associated protein (tastin)
TUBA1B NM_006082 hypothetical gene supported by AF081484; NM_006082; tubulin,a 1b
TXLNG NM_001168683 g-taxilin
TXNRD1 NM_001093771 thioredoxin reductase 1; hypothetical LOC100130902
WDR13 NM_001166426 WD repeat domain 13
WDR36 NM_139281 WD repeat domain 36
WNK1 NM_014823 WNK lysine deficient protein kinase 1
YWHAZ NM_145690 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, z polypeptide
ZAK NM_133646 sterile a motif and leucine zipper containing kinase AZK
ZBTB9 NM_152735 zinc finger and BTB domain containing 9
ZDHHC7 NM_001145548 zinc finger, DHHC-type containing 7
ZNF215 NM_013250 zinc finger protein 215
ZNF616 NM_178523 zinc finger protein 616
ZNF714 NM_182515 zinc finger protein 714
ZNF740 NM_001004304 zinc finger protein 740
List of nonredundant RefSeq protein-coding genes containing CstF-64 CLIP regions (supported by at least two read-alignments) within poly(A) site
regions (extended 200 nt downstream). These genes represent candidates for the CoTC termination mechanism. ‘‘Ribonucleoprotein complex’’
and ‘‘RNA binding’’ GO-TERMs were significantly enriched (Benjamini < 0.05) among these genes (DAVID Bioinformatics Resources). HBB derives
from CLIP1 where cells were transfected with the b-globin expression plasmid bTERM.level signal over probes A and U3. NRO analysis of control
construct b4-7, which includes an 850 bp spacer sequence in
place of the terminator, confirms that the effect of CCNB1
and PTCH2 PCTEs on the NRO profile is due to the presence
of authentic Pol II terminator signals and not to arbitrary
spacing effects.
The CCNB1 Terminator Mediates CoTC Activity
Having confirmed that a subset of PCTEs mediate efficient Pol II
termination, we next conducted further analysis of two PCTEs to
measure CoTC activity. Detailed analysis of the human b-globin
CoTC terminator shows that cotranscriptional cleavage of termi-
nator transcripts precedes Pol II disengagement from the DNA
template (Figure 1A) (Dye and Proudfoot, 2001; West et al.,
2008). To determine if a similar order of events occurs at theCCCNB1 terminator, we began by measuring the distribution of
transcribing Pol II in the endogenous CCNB1 terminator region,
by qRT-PCR analysis of nascent transcripts. Total nuclear RNA
was reverse transcribed using random primers and the resulting
cDNA was PCR amplified, using primer pairs to detect tran-
scripts of the CCNB1 poly(A) site and terminator regions (see
upper diagram, Figure 5A). The resulting PCR products were
quantified by PhosphoImage analysis before plotting on the
graph (gray bars, Figure 5A). PCR amplification, using primer
pair F1/R1, results in a prominent signal reflecting the high abun-
dance of transcripts in the poly(A) site region. PCR amplification
of cDNA representing CCNB1 terminator transcripts, using
primer pair F2/R2, indicates relatively high transcript abundance
at the 50 end of the terminator. However, transcript abundance is
significantly decreased by the middle of the terminator, primerell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authors 1085
Figure 2. Nuclear Distribution of Pre-mRNA from CstF-64 CLIP
Positive and Negative Gene Loci
CLIP positive (A) and negative (B) gene names are shown to the left of the
corresponding data panels. RT-PCR analysis was performed on pre-mRNA
fromchromatin (Ch, lanes 1 and3) and nucleoplasm (N, lanes 2 and4) fractions.
cDNA synthesis was primed using random primers, in reactions with (+RTase,
lanes 1 and 2) or without (RTase, lanes 3 and 4) the addition of reverse tran-
scriptase to control for the presence of contaminating DNA. PCR amplification
(23 cycles) of the resulting cDNA was conducted using gene-specific primers
(indicated by blue arrows in the diagrams above the data panels) spanning
annotated poly(A) sites (UCSC Genome Browser; http://genome.ucsc.edu/).
(The number of PCR cycles was determined to be within the linear range [data
not shown] and therefore accurately reflects RNA abundance). Radiolabeled
RT-PCR products from chromatin and nucleoplasm fractions (lanes 1 and 2)
were quantitated by PhosphoImage analysis and the proportion of released
nucleoplasmic pre-mRNA (% total) calculated and displayed in the graphs
below the data panels. The lack of PCR products in lanes 3 and 4 (RTase)
confirms the absence of contaminating DNA in all samples. The diagrams
above thedatapanels illustratingCoTC-type (A) andpause-type (B) termination
mechanisms are labeled as Figure 1A, except for the pause element (blue bar)
and scissors (indicating cleavageby the30 endprocessing complex) in (B). Error
bars represent the results of three experimental repeats.pair F3/R3, falling to 10% at the 30 end of the terminator
element (primer pair F4/R4). Examination of the post-terminator
region, using primer pair F5/R5, indicates a further decrease in
active Pol II level. These data show that the level of transcription-
ally engaged Pol II decreases as it proceeds through the termi-
nator region, indicative of Pol II termination. We next examined
the continuity of CCNB1 terminator transcripts by qPCR of1086 Cell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authorsrandom primed cDNA, using primer pairs composed of a single
forward primer (F1), located immediately upstream of the
CCNB1 poly(A) site, in combination with five different reverse
primers (R1–R5; see lower diagram, Figure 5A). The resulting
radioactive PCR products were quantified by PhosphoImage
analysis before plotting on the graph (black bars, Figure 5A).
This analysis shows that whereas high levels of continuous tran-
scripts are detected with reverse primers positioned before the
terminator element, very few or none (7%–0%) are detected
with primers positioned within or downstream of the terminator
element. These data show that nascent transcripts of the 50
end of the CCNB1 terminator are cotranscriptionally cleaved
and, when combined with results from the measurement of
transcript distribution above, indicate that transcript cleavage
precedes Pol II termination occurring throughout the CCNB1
terminator. The profile of transcript discontinuity followed by
Pol II termination is similar to that described for the human
b-globin gene terminator (Dye and Proudfoot, 2001) and is indic-
ative of the presence of the CoTC termination mechanism at the
CCNB1 gene locus. To test if other candidate genes utilize the
CoTC termination pathway we conducted analogous qRT-PCR
terminator transcript analysis on the endogenous WDR13 gene
and observed terminator transcript discontinuity occurring
before Pol II termination, again indicating the presence of the
CoTC termination mechanism (Figure S2).
Terminator and CoTC Activities Localize to the 50 End of
the CCNB1 Terminator Element
To analyze the CCNB1 terminator in more detail, it was divided
into three subfragments (labeled A, B, and C) that were placed
in the reporter plasmid bDTERM, forming bCCNB1A, bCCNB1B,
and bCCNB1C (diagram, Figure 5B). The termination capacity of
each subfragment was compared to that of the full-length
CCNB1 terminator (in bCCNB1) by RPA. Nuclear RNA isolated
from HeLa cells transiently transfected with bCCNB1/A/B and
C, positive (bTERM) and negative (bDTERM) control constructs
and pTat, were hybridized to an antisense radiolabeled ribop-
robe spanning the HIV-LTR (Figure 5B). The positive (bTERM,
lane 2) and negative (bDTERM, lane 3) controls show that bTERM
promotes efficient Pol II termination, as indicated by the reduced
read-through signal in lane 2. In lane 4 (bCCNB1), restoration of
read-through and mRNA protection products, to the levels seen
with the termination positive control bTERM (lane 2), confirms
that the full CCNB1 terminator mediates efficient Pol II termina-
tion. In lane 5 (bCCNB1A) a similar pattern of low read-through
and high mRNA signal is observed, indicating that region A of
the CCNB1 terminator mediates efficient Pol II termination. In
lanes 6 (bCCNB1B) and 7 (bCCNB1C), the significantly lower
level of the mRNA band and higher level of the read-through
band indicates that regions B and C of the CCNB1 terminator
have reduced terminator activity. This observation is confirmed
by quantitative phosphoImage analysis of the radiolabeled pro-
tection products, shown in the graph below the data panel.
We next tested the CCNB1 terminator subfragments for
CoTC activity by measuring transcript abundance using
qRT-PCR. Nuclear RNA isolated from HeLa cells transiently
transfected with bCCNB1/A, B, or C and pTat, was reverse tran-
scribed with PCR primers labeled BR and terR, which are
Figure 3. Mapping CoTC Terminator Elements at Endogenous Gene Loci
(A) RT-PCR analysis of CCNB1 30 flanking region transcripts using primer pairs indicated (blue arrows) in the diagram below the data panel. Lanes 1–5, control
PCR amplification of genomic DNA. Lanes 6–10 (+RTase) PCR amplification of reverse transcribed CCNB1 30 flanking region transcripts. Lanes 11–15, control
PCR amplification ofRTase samples. The diagram below the data panel shows theCCNB1 30 UTR (gray box), poly(A) site (green arrowhead), and putative CoTC
terminator element (PCTE, red bar).
(B) RT-PCR analysis of PTCH2, THOC2, AKIRIN1, andWDR13 30 flanking region transcripts. Sample lanes and diagram notation are as in (A). *In PTCH2 lane 8,
indicates nonspecific RT-PCR products of unknown origin. Control PCR amplification (RTase, lanes 11–15) confirms the absence of contaminating DNA.
See also Figure S1.complementary to plasmid sequence either side of the inserted
CCNB1 terminator subfragments (diagram, Figure 5C). We
then conducted PCR on the resultant cDNA using primer pairsCBF/BR and terF/terR to analyze transcripts from upstream of
and across the terminator subfragments (Figure 5C). The
absence of PCR products in lane 1 confirms that there is noell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authors 1087
Figure 4. Measuring Terminator Efficiency
(A) Diagram of the bDTERM construct. The tran-
scription start site (gray arrow), poly(A) site (green
arrowhead, labeled pA), insertion site of PCTEs,
and b-globin terminator (red bar) are indicated. The
HIV-LTR antisense riboprobe (tailed rectangle),
expected readthrough (RT), and mRNA (P) pro-
tection products (blue bars) are also shown.
(B) RNase protection termination assay (RPA).
Lane 1, untransfected cells, lanes 2–8 transfected
cells. Control RNase digestion of the riboprobe is
shown in lane 9 (tRNA+) beside undigested ribop-
robe (tRNA, lane 10). For each sample RT and P
protection products were quantified by Phospho-
Image analysis and the relative abundance of the
RT product (RT/Total) was calculated and dis-
played in the graph below the data panel. Error
bars represent the results of three experimental
repeats.
(C) Nuclear run on (NRO) analysis of CCNB1 and
PTCH2 terminator elements. In the diagram, above
the data panel, positions of single strand (ss) DNA
probes, with respect to the plasmid template, are
indicated by characters in bold. Slot blots in the
data panel show the distribution of nascent tran-
scripts from the plasmid templates indicated to the
left of the panel. The bar graph, below the data
panel, shows quantitation of NRO hybridization
signals after removal of background hybridization
signal, detected by control probe M (M13 DNA),
and correction for [a-32P]UTP content of the
hybridized nascent transcripts.background signal in untransfected HeLa cells. In lane 2
(bCCNB1A) amplification with the BF/BR primer pair yields a
prominent PCR product, representing transcripts from upstream
of terminator subfragment A. However, PCR amplification of the
region A transcript, with the terF/terR primer pair, results in a very
low abundance PCRproduct indicating that few continuous RNA
transcripts extend across this region. In contrast, bCCNB1/B
and C generated prominent PCR products with both primer
pairs, indicating that abundant continuous RNA transcripts
extend across these subfragments of the CCNB1 terminator.
The very low level of RT-PCR product representing transcripts
of subfragment A indicates that they are subject to CoTC. The
correspondence of the robust terminator activity of subfragment
A, shown by RPA (Figure 5B), and the observed discontinuity of
its transcript, shown both here (lane 2, Figure 5C) and in qRT-
PCR of terminator transcripts from the endogenous gene locus
(Figure 5A), contrasts with the weak terminator activity and
apparent stability of region B and C transcripts. These data pro-
vide further compelling evidence that Pol II termination on the
CCNB1 gene is mediated by the CoTC termination mechanism
and confirm that, using the CLIP-seq strategy, we have success-
fully identified authentic Pol II terminator elements.1088 Cell Reports 3, 1080–1092, April 25, 2013 ª2013 The AuthorsBioinformatic Analysis of CoTC
Terminator Sequences
In order to search for conserved DNA or
RNA sequences involved in the CoTC
termination mechanism we next con-ducted a detailed bioinformatic analysis of the 30 flanking re-
gions (0–2 kb downstream of the CLIP-seq sites) of all 78
CoTC candidate genes. From this analysis we found that candi-
date gene 30 flanking regions are slightly more AT- and T-rich
than equally sized regions downstream of the annotated pA sites
of other protein coding genes (Figure S3). This finding is in
agreement with our analysis of the b-globin terminator that has
shown the importance of AT rich sequences in CoTC-mediated
termination of b-globin gene transcription (Dye and Proudfoot,
2001; White et al., 2013). Next, in an effort to identify possible
trans-acting factors in the CoTC termination process, we
screened the candidate gene 30 flanking regions for the pres-
ence of DNA binding motifs of known transcription factors
represented in the professional version of the TRANSFAC data-
base, which includes 1,665 binding motif matrices. We found
that none of these motifs were significantly enriched or depleted
in the tested set when compared to the corresponding region of
other protein coding genes. Finally, we conducted a search for
potential novel sequence motifs by using MEME software
(Bailey and Elkan, 1994). Although, as expected, some weak
motifs were identified in a subset of candidate gene 30 flanking
regions using this approach (see Figure S4), their relevance to
Figure 5. Mapping of CoTC Termination Activity in the CCNB1 30 Flanking Region
(A) Graph showing results of qRT-PCR analysis of transcript distribution (gray bars) and transcript continuity (black bars) at the CCNB1 gene terminator.
Diagrams, below the graph, show primer pairs (blue arrows) used in transcript distribution and transcript continuity analyses. The CCNB1 poly(A) site (green
arrowhead) and terminator element (red bar) are indicated. In the graph, (*) indicates that no PCR product was detected with the indicated primer pairs. Error bars
represent the results of three experimental repeats.
(B) RPA of CCNB1 terminator fragments. In the diagram of the bDTERM reporter plasmid, dashed red lines indicate the insertion site of CCNB1 terminator
fragments (labeled colored bars). Lane 1, untransfected cells, lanes 2–7 transfected cells. Control RNase digestion of the riboprobe is shown in lane 8 (tRNA+)
beside undigested riboprobe (tRNA, lane 9). For each sample RT and P protection products were quantified by PhosphoImage analysis and the relative
abundance of the RT product (RT/Total) was calculated and displayed in the graph below the data panel. Error bars represent the results of three experimental
repeats.
(C) qRT-PCR analysis of the continuity ofCCNB1 terminator subfragment transcripts. In the diagram, the location of PCR primers (red and blue arrows), relative to
terminator fragments (red bar) is shown. Lane 1, qRT-PCR of untransfected cells. Lanes 2–4, cells transfected withCCNB1 terminator fragment constructs. Lanes
5–8, control qRT-PCR ofRTase samples. cDNA in all samples was amplified using 15 PCR cycles (data not shown), whichwas determined to bewithin the linear
range and therefore accurately reflects RNA abundance.
See also Figure S2.transcription termination is not clear. Thus our bioinformatic
analysis shows that CoTC terminators are not characterized
by a simple sequence motif and indicates that factors apart
from DNA sequence are involved in the CoTC termination
process.CDISCUSSION
Transcription termination is an important, yet relatively over-
looked, aspect of the Pol II transcription cycle. Major reasons
for this are the considerable technical difficulties involved inell Reports 3, 1080–1092, April 25, 2013 ª2013 The Authors 1089
the analysis of nascent Pol II transcripts and the fact that Pol II
termination has not as yet, been recapitulated in vitro. However,
the finding that Pol II transcription termination on the human
b-globin gene, which occurs by the CoTC terminator mechanism
(Dye and Proudfoot, 2001), involves release of b-globin pre-
mRNA from the chromatin template to the nucleoplasm (West
et al., 2008) has enabled us to develop amethod for identification
of Pol II terminator elements. We have conducted IP of nucleo-
plasmic RNA, using antibody against the pre-mRNA processing
factor CstF-64, to select pre-mRNAs that are released from tran-
scription sites prior to 30 end processing. Mass sequencing of
such CstF-64 interacting pre-mRNAs enabled the identification
of 78 candidate genes for the CoTC termination pathway.
Detailed transcriptional analysis of the 30 flanking regions of a
randomly selected subset of five candidate genes (CCNB1,
PTCH2, WDR13, THOC2, and AKIRIN1), resulted in the identifi-
cation of CoTC terminator elements located 0.5–2 kb down-
stream of the candidate gene poly(A) sites. Each terminator
element promotes efficient Pol II termination with the most
potent, from the CCNB1 and PTCH2 gene 30 flanking regions,
mediating 100% Pol II termination in nuclear run on assays.
From these results we predict that the remaining 73
candidate genes contain CoTC terminators within their 30 flank-
ing regions.
Although we have identified CoTC terminators at a number of
gene loci, our data indicate that this number is limited because
we have not reached saturation in identification of unprocessed
pre-mRNAs in the nucleoplasm. This is possibly due to both the
relatively low abundance of these species and gene-specific
variation in the strength of the poly(A) site-CstF-64 interaction
(Takagaki and Manley, 1997; Martin et al., 2012). Thus it is likely
that many more protein coding genes employ the CoTC termina-
tion mechanism. Supporting evidence for this suggestion comes
from an electron microscopic study of Pol II transcription in
Drosophila. In this study, of over 100 unidentified Pol II tran-
scribed genes, it was found that Pol II termination and pre-
mRNA release occurred prior to pre-mRNA 30 end processing
for 64%of these genes (Osheim et al., 2002). Although themech-
anism of Pol II termination at these gene loci is unknown, the
observation of abundant released pre-mRNA is suggestive of a
CoTC-type termination pathway.
In order to understand more about the possible role of DNA
sequence in the CoTC termination mechanism we conducted
a detailed bioinformatic analysis of the 30 flanking regions
(0–2 kb downstream of the CLIP-seq sites) of all 78 CoTC candi-
date genes. From this analysis, we found that these regions are
more AT- and T-rich than equally sized regions downstream of
the annotated pA sites of other protein coding genes. Although
a search for known transcription factor DNA binding motifs in
the candidate gene 30 flanking regions, using the TRANSFAC
database (1,665 binding motif matrices), revealed no matches,
a search for potential novel sequence motifs using MEME
software (Bailey and Elkan, 1994) did identify a number of
weak motifs in a subset of candidate gene 30 flanking regions.
Further work will be required to determine the importance of
these sequence motifs in the CoTC termination process.
Combining these data with our understanding of the role of AT-
rich sequences in the human b-globin terminator (Dye and1090 Cell Reports 3, 1080–1092, April 25, 2013 ª2013 The AuthorsProudfoot, 2001: White et al., 2013) enables us to state that
CoTC terminator sequences are complex and are not character-
ized by a simple sequence motif. An interesting possibility is that
the length and sequence composition of CoTC terminator
elements may have affects on nucleosome organization (Kaplan
et al., 2009) that may be instrumental in the Pol II termination
process.
Apart from mapping CoTC terminators our CLIP-seq strategy
illuminates another termination pathway at endogenous gene
loci. Analysis of pre-mRNA from the GAPDH, PKM2, and
ENO1 genes (that were not selected by IP of nucleoplasmic
pre-mRNA) shows that for these genes, cotranscriptional poly(A)
site cleavage precedes release of Pol II from the chromatin
template. Such an order of events corresponds to the pausing
model of transcription termination where it is envisioned that
G-rich sequences, located immediately downstream of the
poly(A) site, cause a transient pause in Pol II progression that
effectively enhances 30 end processing (Gromak et al., 2006).
In agreement with this model the GAPDH, PKM2, and ENO1
genes all have enrichment of G residues in the post poly(A) site
region, which correlates with a recent chromatin immunoprecip-
itation (ChIP) analysis showing significant Pol II accumulation at
the 30 ends of the GAPDH and ENO1 genes (Brannan et al.,
2012).
Although we have discussed Pol II termination in terms of
CoTC and pausing models (Figure 6) this may be an oversimpli-
fication. Results herein and in previous analyses of CoTC
sequences, show significant variation in CoTC terminator effi-
ciency (Dye and Proudfoot, 2001; Plant et al., 2005; West
et al., 2006). Considering the sequence-specificity of CoTC
(AT-rich) and pause (G-rich) terminator elements, it is likely that
the relative contribution of each termination mechanism, at indi-
vidual gene loci, is directed by 30 flanking region sequence
composition. This leads us to speculate that, especially in the
light of the observation that CoTC termination can enhance
levels of gene expression (West and Proudfoot, 2009), gene-
specific 30 flanking region sequence composition could have
subtle, but important, effects on gene expression.
This studymarks a successful attempt to map Pol II terminator
elements at endogenous gene loci. It has enabled the character-
ization of a significant number of CoTC terminator elements,
which we predict to be a common feature of mammalian genes,
and the visualization of a different termination mechanism,
possibly pause-type, occurring at gene loci that were not
selected using the CLIP-seq methodology. We anticipate that
application of the range of techniques described herein will
enable the definition of many more terminator elements and
lead to a deeper understanding of mammalian Pol II termination
pathways and their roles in gene expression.
EXPERIMENTAL PROCEDURES
PCR Primers and RNA Linkers
A list of oligonucleotide sequences used as PCR primers and RNA linkers is
given in Table S1.
Plasmid Constructions
pTat, bTERM, bDTERM, and b4-7 (formerly bD5–7, bD5–10, and bD8–10) have
been described previously (Dye and Proudfoot, 2001). bCCNB1, bPTCH2,
Figure 6. Diagram of CoTC and Pause-Type
Pol II Termination Pathways
In the CoTC termination pathway transcripts of
AT-rich terminator elements (red bar) are cleaved
by CoTC activity (red scissors) promoting Pol II
release before poly(A) site cleavage, mediated by
the 30 processing complex (green scissors). In the
pause-type termination pathway, Pol II transcrip-
tional pausing, at G-rich sequences (blue bar),
enhances pre-mRNA cleavage at the poly(A) site,
leading to Pol II release. Icons and symbols as in
Figure 1A.bAKIRIN1, bTHOC2, bWDR13, and bCCNB1/A/B and C expression plasmids
were made by insertion of genomic PCR fragments, isolated using gene-
specific primer sets, into a cloning vector prepared by long range PCR
amplification (Barnes, 1994) of bDTERMwith primers BETA43/BETA10.3 using
PrimeSTAR HS DNA polymerase (Takara).
Transfection Procedure
Transient transfection of HeLa cells was performed as previously described
(West et al., 2008).
Nuclear RNA Fractionation
Nuclear RNA fractionation was performed as previously described (West et al.,
2008).
RNA Immunoprecipitation
HeLa cells on 10 cm plates were irradiated with 254 nm UV (300 mJ/cm2)
prior to nuclear fractionation. RNA in the nucleoplasm fraction was immuno-
precipitated with either rabbit IgG or CstF-64 antibody (Cambridge Biosci-
ence) conjugated to Protein G Dynabeads (Invitrogen). Following 1 hr incuba-
tion at 4C, beads were washed four times with NET-2 buffer (10 mM Tris-HCl
pH7.5, 150 mM NaCl, 0.05% NP-40) and precipitated RNA eluted in Trizol
(Invitrogen).
HITS Library Preparation and Data Processing
HITS library preparation was performed as described (Licatalosi et al., 2008).
Samples from three independent repeats of CstF-64 CLIP-seq were sub-
mitted to high-throughput sequencing from the 50 ends using the Illumina
Hi-Seq 100 nt single-end reads protocol (Source Bioscience). Repeats 1
and 2 were multiplexed and sequenced together in the same lane. During
pre-processing, samples 1 and 2 were demultiplexed using barcodes; low
quality reads (mean Q < 30 within the first 50 bases) were removed and 30
sequences matching ligated adaptors or putative oligo-A tails trimmed. Reads
shorter than 24 nt were discarded and longer reads trimmed to 50 nt before
Bowtie alignment to the hg18 assembly of the human genome allowing for
three mismatches. From a total of 97.5 M reads (40.1 M, 32.9 M and
24.5 M, in repeats 1, 2, and 3, respectively), 49.8 M aligned, of which
38.5 M (13.1 M, 10.9 M, and 13.8 M in repeats 1, 2, and 3, respectively)
matched unique sites (only these were considered in the subsequent
analysis). Each of the experimental repeats resulted in a high level of duplica-Cell Reports 3, 1080–109tion indicated by many reads aligned to the
same genomic location, probably due to the low
amount of pre-mRNA targets recovered from the
nucleoplasm in the CLIP experiment. To avoid
bias PCR duplicates were removed and each
unique read-alignment location was considered
only once, resulting in 9,658 (3,410, 2,765, and
3,483, in repeats 1, 2, and 3, respectively) read-
alignment sites. To maximize sensitivity reads
from the three repeats were pooled for subse-
quent analysis. Overlapping read-alignments(extended by 100 bp) were merged to ‘‘regions.’’ A total of 1,285 regions,
supported by at least two independent read-alignments, were considered sig-
nificant. Many regions were identified in only one repeat, indicating that the
experiment was far from saturation in detection of nucleoplasmic CstF-64
binding targets. To determine their genomic distribution, significant regions
were related to NCBI RNA reference sequences (RefSeq) and short RNA
gene (RNA genes) annotation tracks, downloaded from the UCSC genome
browser. To identify genes that employ the CoTC termination pathway we
selected pre-mRNAs with a CstF-64 CLIP region in 30 UTRs, extended by
200 bp downstream (to account for variability in poly(A) site usage and impre-
cision in transcript-end annotation).
RT-PCR and qRT-PCR
cDNA was synthesized using Superscript III (Invitrogen). DNA amplification
was performed using Go-Taq DNA polymerase (Promega). When conducting
qRT-PCR, PCR products were amplified with [a-32P]dCTP (Perkin Elmer). PCR
products were applied to 6% polyacrylamide gels and radioactive signals
quantified by PhosphoImager (Fuji).
RNase Protection Analysis
RNase protection analysis is as described previously (Plant et al., 2005).
NRO Analysis and Single-Stranded DNA probes
NRO analysis and single-stranded M13 probes used are as described
previously (West et al., 2008). Quantitation of NRO hybridization signals by
PhosphoImager analysis is based on the average of multiple experiments after
subtraction of background signal, shown by probe M.
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